[Prevention, by antidiabetic biguanides, of hepatic cholesteatosis induced by cholesterol in the rabbit. Histopathological examination].
D000818:Animals; D001645:Biguanides / Q000008:administration & dosage / Q000494:pharmacology*; D055598:Chemical Phenomena; D002621:Chemistry; D002784:Cholesterol; D005234:Fatty Liver / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008112:Liver Glycogen / Q000032:analysis; D008297:Male; D011817:Rabbits
D001645:Biguanides; D007004:Hypoglycemic Agents; D008112:Liver Glycogen; D002784:Cholesterol
Prévention par les biguanides antidiabétiques de la cholestéatose hépatique induite par le cholestérol chez le lapin. Examen histopathologique.